Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome.
CAPS
LRR
Leucine-Rich Repeat domain
NLRP3
inflammasome
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
16 Aug 2024
16 Aug 2024
Historique:
received:
09
07
2024
revised:
02
08
2024
accepted:
04
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
28
8
2024
Statut:
epublish
Résumé
The NLRP3 inflammasome is a critical component of the innate immune response. NLRP3 activation is a tightly controlled process involving an initial priming to express NLRP3, pro-IL-1 β, and pro-IL-18, followed by an activation signal. The precise mechanism of activation is not fully understood due to the diverse range of activators, yet it effectively orchestrates the activation of caspase-1, which subsequently triggers the release of proinflammatory cytokines IL-1β and IL-18. NLRP3 dysregulation can lead to a variety of inflammatory diseases, highlighting its significant role in immune response and disease pathogenesis. NLRP3 is divided into three domains: the PYD, the NACHT, and the LRR domains. This review focuses on the LRR domain of NLRP3, detailing its structural characteristics, its function in pathogen sensing, its role in the degradation process, and its involvement in inflammasome auto-inhibition and activation. Additionally, we discuss the impact of mutations within the LRR domain found in atypical Cryopyrin-Associated Periodic Syndromes (CAPS), highlighting the clinical relevance of this domain.
Identifiants
pubmed: 39195255
pii: cells13161365
doi: 10.3390/cells13161365
pii:
doi:
Substances chimiques
NLR Family, Pyrin Domain-Containing 3 Protein
0
Inflammasomes
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM